Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Allogene Therapeutics (ALLO) Institutional Ownership

Allogene Therapeutics logo
$2.00 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$2.00 0.00 (0.00%)
As of 05/22/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)

Current
Institutional Ownership
Percentage
83.63%
Number of
Institutional Buyers
(last 12 months)
67
Total
Institutional Inflows
(last 12 months)
$35.40M
Number of
Institutional Sellers
(last 12 months)
39
Total
Institutional Outflows
(last 12 months)
$31.39M
Get ALLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALLO Institutional Buying and Selling by Quarter

Allogene Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2026 Essential Partners LLC19,410$47K0.0%+525.9%0.008%
5/19/2026 Bank of America Corp DE2,134,473$5.21M0.0%+111.9%0.872%
5/19/2026 Bull Harbor Capital LLC12,703$31K0.0%N/A0.005%
5/18/2026 Royal Bank of Canada56,532$138K0.0%+15.9%0.023%
5/16/2026 The Manufacturers Life Insurance Company 654,180$1.60M0.0%+35.0%0.267%
5/14/2026 Renaissance Technologies LLC2,139,328$5.22M0.0%-2.2%0.874%
5/14/2026 Public Employees Retirement System of Ohio177,875$434K0.0%N/A0.073%
5/7/2026 Dimensional Fund Advisors LP1,201,655$2.93M0.0%+25.5%0.491%
5/5/2026 Bank of New York Mellon Corp395,187$964K0.0%-2.6%0.161%
5/1/2026 Candriam S.C.A.2,997,318$7.31M0.0%+30.0%1.224%
4/30/2026 Hsbc Holdings PLC260,404$638K0.0%+75.8%0.106%
4/30/2026 Harold Davidson & Associates Inc.289,222$706K0.3%+48.5%0.118%
4/29/2026 R Squared Ltd45,245$110K0.1%-47.5%0.018%
4/28/2026 Abel Hall LLC26,647$65K0.0%+56.4%0.011%
4/20/2026 Kestra Private Wealth Services LLC10,909$27K0.0%N/A0.004%
4/17/2026 Krilogy Financial LLC16,780$40K0.0%N/A0.007%
4/16/2026 SG Americas Securities LLC15,390$38K0.0%-35.8%0.006%
3/20/2026 Hsbc Holdings PLC148,136$199K0.0%+57.5%0.061%
3/3/2026 Caitong International Asset Management Co. Ltd44,334$61K0.0%+84.4%0.020%
2/23/2026 Virtu Financial LLC42,351$58K0.0%+55.9%0.019%
2/19/2026 Invesco Ltd.609,807$835K0.0%+16.1%0.271%
2/18/2026 Mercer Global Advisors Inc. ADV29,512$40K0.0%+23.0%0.013%
2/18/2026 XTX Topco Ltd476,307$653K0.0%-38.5%0.212%
2/18/2026 Zacks Investment Management192,731$264K0.0%-63.4%0.086%
2/18/2026 Virtus Investment Advisers LLC176,178$241K0.1%+116.8%0.078%
2/18/2026 Quadrature Capital Ltd274,416$376K0.0%+15.3%0.122%
2/18/2026 Millennium Management LLC1,841,307$2.52M0.0%-45.7%0.819%
2/18/2026 Man Group plc526,106$721K0.0%+86.5%0.234%
2/17/2026 AQR Capital Management LLC1,429,247$1.96M0.0%-22.9%0.636%
2/17/2026 Price T Rowe Associates Inc. MD3,209,275$4.40M0.0%-12.7%1.428%
2/17/2026 Russell Investments Group Ltd.40,041$55K0.0%+83.3%0.018%
2/17/2026 Captrust Financial Advisors53,101$73K0.0%+237.9%0.024%
2/17/2026 Royal Bank of Canada48,794$67K0.0%-95.6%0.022%
2/17/2026 Graham Capital Management L.P.148,671$204K0.0%-24.7%0.066%
2/16/2026 Squarepoint Ops LLC104,656$143K0.0%-61.0%0.047%
2/16/2026 Barclays PLC642,687$880K0.0%+7.3%0.286%
2/13/2026 Marshall Wace LLP285,561$391K0.0%N/A0.127%
2/13/2026 CANADA LIFE ASSURANCE Co50,951$69K0.0%+28.2%0.023%
2/13/2026 Kalehua Capital Management LLC2,546,129$3.49M3.2%N/A1.133%
2/13/2026 Smartleaf Asset Management LLC28,927$38K0.0%N/A0.013%
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
2/13/2026 Headlands Technologies LLC46,778$64K0.0%-66.6%0.021%
2/13/2026 OpenArc Corporate Advisory LLC162,984$223K0.0%N/A0.073%
2/13/2026 Charles Schwab Investment Management Inc.1,355,809$1.86M0.0%+16.4%0.603%
2/13/2026 State Street Corp2,761,400$3.78M0.0%+0.2%1.229%
2/13/2026 Ieq Capital LLC435,267$596K0.0%+15.7%0.194%
2/13/2026 Wells Fargo & Company MN200,276$274K0.0%+38.3%0.089%
2/12/2026 HRT Financial LP72,751$99K0.0%-45.1%0.032%
2/12/2026 MetLife Investment Management LLC34,823$48K0.0%-39.2%0.015%
2/12/2026 Renaissance Technologies LLC2,187,084$3.00M0.0%-24.4%0.973%
2/12/2026 Dimensional Fund Advisors LP957,816$1.31M0.0%-54.2%0.426%
2/12/2026 Patient Square Capital LP4,963,756$6.80M1.5%+66.5%2.209%
2/11/2026 Primecap Management Co. CA8,139,840$11.15M0.0%+15.0%3.622%
2/11/2026 Deutsche Bank AG131,086$180K0.0%-6.9%0.058%
2/11/2026 Cerity Partners LLC97,909$134K0.0%-79.0%0.044%
2/11/2026 LPL Financial LLC170,750$234K0.0%-3.8%0.076%
2/11/2026 Harold Davidson & Associates Inc.194,753$267K0.1%-34.1%0.087%
2/10/2026 Goldman Sachs Group Inc.2,289,458$3.14M0.0%+90.2%1.019%
2/10/2026 Intech Investment Management LLC86,637$119K0.0%+20.5%0.039%
2/9/2026 Geode Capital Management LLC3,932,910$5.39M0.0%+2.6%1.750%
2/6/2026 GSA Capital Partners LLP613,998$841K0.1%+235.7%0.273%
2/5/2026 Navalign LLC49,398$68K0.0%-17.5%0.022%
1/30/2026 R Squared Ltd86,215$118K0.1%+40.5%0.038%
1/23/2026 Choreo LLC38,849$51K0.0%N/A0.017%
1/16/2026 Aberdeen Group plc2,086,332$2.86M0.0%+31.9%0.928%
1/1/2026 JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.404%
11/19/2025 Caitong International Asset Management Co. Ltd24,047$30K0.0%+5,267.6%0.011%
11/17/2025 CANADA LIFE ASSURANCE Co39,730$50K0.0%+27.3%0.018%
11/17/2025 XTX Topco Ltd774,203$960K0.0%+2,687.7%0.345%
11/17/2025 Scientech Research LLC26,635$33K0.0%N/A0.012%
11/17/2025 Mercer Global Advisors Inc. ADV23,998$30K0.0%N/A0.011%
11/17/2025 Millennium Management LLC3,390,026$4.20M0.0%+125.6%1.508%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.164,780$204K0.0%-8.2%0.073%
11/17/2025 Bank of America Corp DE974,320$1.21M0.0%-1.3%0.434%
11/14/2025 Zacks Investment Management526,132$652K0.0%+2.7%0.234%
11/14/2025 Two Sigma Investments LP3,383,644$4.20M0.0%+109.7%1.506%
11/14/2025 Bridgeway Capital Management LLC250,000$310K0.0%N/A0.111%
11/14/2025 Squarepoint Ops LLC268,044$332K0.0%+1,383.7%0.119%
11/13/2025 Lynx1 Capital Management LP546,119$677K0.1%-95.1%0.243%
11/13/2025 UBS Group AG3,571,157$4.43M0.0%+75.1%1.589%
11/13/2025 BNP Paribas Financial Markets894,314$1.11M0.0%+1.7%0.398%
11/13/2025 Russell Investments Group Ltd.21,844$27K0.0%+11,159.8%0.010%
11/13/2025 Dynamic Technology Lab Private Ltd39,677$50K0.0%N/A0.018%
11/12/2025 Barclays PLC598,997$743K0.0%-7.2%0.267%
11/12/2025 Dimensional Fund Advisors LP2,090,753$2.59M0.0%-23.6%0.930%
11/12/2025 R Squared Ltd61,373$76K0.0%+88.8%0.027%
11/12/2025 Primecap Management Co. CA7,079,308$8.78M0.0%+23.8%3.150%
11/12/2025 Intech Investment Management LLC71,895$89K0.0%-27.1%0.032%
11/10/2025 TD Asset Management Inc414,074$513K0.0%-24.1%0.184%
11/10/2025 Patient Square Capital LP2,981,396$3.70M1.0%+13.1%1.327%
11/7/2025 Harold Davidson & Associates Inc.295,432$366K0.2%+118.5%0.133%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
11/7/2025 Levin Capital Strategies L.P.52,500$65K0.0%N/A0.024%
11/7/2025 GSA Capital Partners LLP182,879$227K0.0%-62.8%0.082%
11/7/2025Vanguard Group Inc.9,020,770$11.19M0.0%+9.2%4.066%
11/7/2025 JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.410%
11/7/2025 Aberdeen Group plc1,582,265$1.96M0.0%+82.4%0.713%
11/5/2025Moloney Securities Asset Management LLC514,000$637K0.1%+92.1%0.232%
11/5/2025 Savant Capital LLC21,645$27K0.0%N/A0.010%
11/3/2025 Coastal Bridge Advisors LLC21,789$27K0.0%-90.1%0.010%
11/3/2025 AustralianSuper Pty Ltd382,141$474K0.0%N/A0.170%
10/31/2025 Vanguard Personalized Indexing Management LLC85,720$106K0.0%+19.6%0.039%


ALLO Institutional Ownership - Frequently Asked Questions

During the previous two years, 145 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), Vanguard Group Inc. ($11.19M), Primecap Management Co. CA ($11.15M), Candriam S.C.A. ($7.31M), Patient Square Capital LP ($6.80M), Perceptive Advisors LLC ($6.35M), and Two Sigma Advisers LP ($5.76M).Learn more on Allogene Therapeutics' institutional investors.

83.63% of Allogene Therapeutics' stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings.

Of the 126 institutional investors that purchased Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($6.90M), Goldman Sachs Group Inc. ($4.83M), Patient Square Capital LP ($4.09M), Foresite Capital Management VI LLC ($3.45M), Primecap Management Co. CA ($3.43M), Perceptive Advisors LLC ($2.73M), and Kalehua Capital Management LLC ($2.55M).

Institutional investors have bought a total of 25,183,673 shares in the last 24 months. This purchase volume represents approximately $35.40M in transactions.

Of the 39 institutional investors that sold Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lynx1 Capital Management LP ($10.51M), JPMorgan Chase & Co. ($4.25M), Dimensional Fund Advisors LP ($1.78M), Millennium Management LLC ($1.55M), Royal Bank of Canada ($1.05M), Renaissance Technologies LLC ($754.48K), and Jane Street Group LLC ($704.05K).

Institutional investors have sold a total of 25,037,869 shares in the last 24 months. This volume of shares sold represents approximately $31.39M in transactions.



This page (NASDAQ:ALLO) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners